Although LA-derived LOX-produced metabolites, 9- and 13-HODEs, have been reported to be increased in the DRG in the spared nerve injury model or in the chemotherapy-induced peripheral neuropathy model (45, 46), we did not observe quantitative changes in these metabolites during our study. This evidence concerns the gene LOX and peripheral neuropathy.